P-11 Update on ADA Panel on Management of Acute Dental Pain

4.5 (4 votes)

CE Hours: 1.0

Description: The FDA funded the development of analgesic prescribing deadlines for the dental profession that was conducted by the ADA and the University of Pittsburgh. The process and results of these deliberations will be presented and critiqued in this presentation.

Learning Objectives: 

  • Attendees will become aware that clinical practice guidelines are limited by the available evidence such that hindsight is not always "20/20"
  • Describe how lasers work and the role of lasers in Radial Apical Cleansing – a new protocol for the management of root canal systems
  • Based on the information presented attendees will be able to manage pain based on the latest national recommendations for safe and efficacious analgesia for acute dental

Key:

Complete
Failed
Available
Locked
Video
Open to view video.
Evaluation
8 Questions
Quiz
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
Certificate
1.00 CE credit  |  Certificate available
1.00 CE credit  |  Certificate available

Raymond Dionne, D.D.S., M.S. Ph.D.

Dr. Dionne received a DDS from Georgetown University and a PhD from the Medical College of Virginia. He conducted clinical and translational pain research at the National Institute of Dental and Craniofacial Research for 34 years, as well as practiced dentistry part-time in the District of Columbia. He is currently a restless retiree living in Missouri.

Speaker Disclosure

In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: AIM Targeted Therapeutics: Consultant on preclinical development of an investigational analgesic formulation (Ongoing); Rilento Pharma: consultant for pre-clinical development of investigational analgesic formulation (Ongoing)